跳至主要内容
临床试验/2023-507758-34-00
2023-507758-34-00已完成1 期

A randomised, placebo-controlled, double-blinded, cross-over, Phase 1 study evaluating the safety and preliminary efficacy of the GLP 1 analogue ROSE-010 on appetite and food intake in overweight and obese subjects.

Rose Pharma Inc.1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2023年11月9日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12
试验地点
1

研究概览

简要总结

暂无简介。

入排标准

年龄范围
18 years 至 65+ years(65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Rose Pharma Inc.
申办方类型
Pharmaceutical company
责任方
Principal Investigator
主要研究者

CTC Clinical Trial Consultants AB, att. Anders Millerhovf

Scientific

Rose Pharma Inc.

研究点 (1)

Loading locations...

相似试验

招募中
1 期
A phase 1, double-blind, placebo-controlled, randomized, single ascending dose and multiple ascending dose study to assess the safety, tolerability, and pharmacokinetics of GHF-201 in healthy adult volunteers
2024-519813-74-00CCDRD Cooperative Clinical Drug Research and Development AG, GHF-Golden Heart Flower Ltd.32
已完成
1 期
A three part randomized, double-blind, placebo-controlled, parallel group SAD and MD clinical study to evaluate the safety, tolerability and preliminary efficacy of an inhaled (nebulized) phage cocktail in healthy subjects and in patients with chronic colonization of the lung with Pseudomonas aeruginosa
2023-507203-55-00Charite Research Organisation GmbH50
招募中
1 期
Randomized, double-blind, placebo-controlled, two-part study assessing the safety, tolerability and pharmacokinetics of BP1.7881 administered as higher doses, after single ascending doses (Part I) and multiple ascending doses (Part II), including the assessment of BP1.7881 on cardiac repolarization, in healthy subjects.Eosinophilic esophagitis
2024-512722-28-00Bioprojet Pharma161
招募中
1 期
Double-blind, randomized, placebo-controlled pilot clinical trial to evaluate the safety, tolerability and efficacy of two doses of a conditioned medium from a co-culture of M2 macrophages and fat-derived mesenchymal cells (PRS CK STORM) in the modulation of the cytokine storm for the treatment of acute respiratory distress syndrome (ARDS) caused by SARS-Cov-2, influenza A, influenza B and respiratory syncytial virus (RSV)
2023-507700-32-00Peaches Biotech S.L.50
招募中
1 期
Inhaled RB042 in Healthy Adult Volunteers, Healthy Adult Smokers and Patients With Chronic Obstructive Pulmonary DiseaseCOPD (Chronic Obstructive Pulmonary Disease)COPD
NCT07285122Atisama Therapeutics105
A randomised, placebo-controlled, double-blinded,... | 临床试验